ERASX
Price
$44.29
Change
-$0.34 (-0.76%)
Updated
Sep 20 closing price
RRMGX
Price
$97.44
Change
-$0.69 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

ERASX vs RRMGX

Header iconERASX vs RRMGX Comparison
Open Charts ERASX vs RRMGXBanner chart's image
Eaton Vance Atlanta Capital SMID-Cap R6
Price$44.29
Change-$0.34 (-0.76%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth R
Price$97.44
Change-$0.69 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
ERASX vs RRMGX Comparison Chart
Loading...
VS
ERASX vs. RRMGX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ERASX is a StrongBuy and RRMGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RRMGX has more cash in the bank: 31.4B vs. ERASX (15.1B). ERASX pays higher dividends than RRMGX: ERASX (0.15) vs RRMGX (0.00). ERASX was incepted earlier than RRMGX: ERASX (10 years) vs RRMGX (22 years). RRMGX is a more actively managed with annual turnover of: 21.70 vs. ERASX (14.00). RRMGX has a lower initial minimum investment than ERASX: RRMGX (2500) vs ERASX (5000000). ERASX annual gain was more profitable for investors over the last year : 24.17 vs. RRMGX (13.62). ERASX return over 5 years is better than : 13.49 vs. RRMGX (9.23).
ERASXRRMGXERASX / RRMGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years22 years-
Gain YTD15.7618.605183%
Front LoadN/AN/A-
Min. Initial Investment50000002500200,000%
Min. Initial Investment IRAN/AN/A-
Net Assets15.1B31.4B48%
Annual Yield % from dividends0.150.00-
Returns for 1 year24.1713.62177%
Returns for 3 years4.93-16.28-30%
Returns for 5 years13.499.23146%
Returns for 10 years83.1833.74247%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OII26.020.16
+0.62%
Oceaneering International
COTY9.19-0.20
-2.13%
COTY
CLCO11.05-0.30
-2.64%
Cool Company Ltd
QLGN0.17-0.01
-3.55%
Qualigen Therapeutics
PRPH2.34-0.17
-6.77%
ProPhase Labs